You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML in first remission, first relapse or subsequent remission

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Decitabine,

Unknown status
  • Acute Myeloid Leukemia
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Dec 18, 2020

Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

Recruiting
  • Acute Myeloid Leukemia
  • Allogeneic Stem Cell Transplantation
  • Tel Aviv, Israel
  • +2 more
Jan 23, 2023

Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

Not yet recruiting
  • Acute Myeloid Leukemia in Remission
  • Nantes, Loire Atlantique, France
  • +22 more
Jun 15, 2023

Leukemia, Myelocytic, Acute Trial in United States (CD34+ selection with CliniMACS device)

Completed
Has Results
  • Leukemia, Myelocytic, Acute
  • CD34+ selection with CliniMACS device
  • Duarte, California
  • +7 more
Oct 21, 2021

Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,

Recruiting
  • Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
  • Duarte, California
  • +12 more
Jan 4, 2023

Acute Myeloid Leukemia Trial in Canada, United States (Clinical Observation, Laboratory Biomarker Analysis, Nivolumab)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Clinical Observation
  • +2 more
  • Birmingham, Alabama
  • +45 more
Dec 30, 2022

MDS, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Pevonedistat)

Completed
Has Results
  • Myelodysplastic Syndromes
  • +2 more
  • Birmingham, Alabama
  • +58 more
Aug 24, 2022

Acute Myeloid Leukemia Trial (Sulfasalazine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Oct 11, 2022

Leukemia, Myeloid, Acute Trial in Seoul (Idarubicin)

Recruiting
  • Leukemia, Myeloid, Acute
  • Seoul, Korea, Republic of
    Division of Hematology-Oncology, Konkuk University Medical Cente
Apr 8, 2022

Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022

Leukemia, Acute Myeloid (AML) Trial in Worldwide (gilteritinib, LoDAC (Low Dose Cytarabine), Azacitidine)

Active, not recruiting
Has Results
  • Leukemia, Acute Myeloid (AML)
  • Birmingham, Alabama
  • +125 more
Aug 9, 2022

MAFLD in Type 2 Diabetes in Jiangsu Province of China

Recruiting
  • Type 2 Diabetes Mellitus in Remission
  • Metabolic Associated Fatty Liver Disease
  • Ultrasound attenuation parameter measurement, fasting blood glucose and fasting insulin determination
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Medical School, Southeast University
Oct 24, 2022

Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 1, 2021

Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

Not yet recruiting
  • Myeloid Malignancy
  • Acute Myeloid Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Suzhou, Jiangsu, China
  • +1 more
Jul 3, 2023

Acute Myeloid Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, MDS Trial in Worldwide (Allogeneic Stem Cell

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +2 more
  • Allogeneic Stem Cell Transplantation
  • Graz, Austria
  • +23 more
Oct 3, 2021

Steroid-Sensitive Nephrotic Syndrome Trial in China (Rituximab)

Recruiting
  • Steroid-Sensitive Nephrotic Syndrome
  • Hefei, Anhui, China
  • +8 more
Jul 26, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

Secondary Acute Myeloid Leukemia Trial in Ann Arbor (Venetoclax, FLAG Protocol)

Not yet recruiting
  • Secondary Acute Myeloid Leukemia
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Mar 22, 2023

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Hangzhou (Azacitidine in Combination With Venetoclax)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Azacitidine in Combination With Venetoclax
  • Hangzhou, Zhejiang, China
    The first Affiliated Hospital of Zhejiang University
Mar 24, 2021

Steroid-Sensitive Nephrotic Syndrome Trial in Shanghai (Rituximab, Corticosteroid)

Not yet recruiting
  • Steroid-Sensitive Nephrotic Syndrome
  • Shanghai, Shanghai, China
  • +2 more
May 6, 2023

ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

Not yet recruiting
  • ALL, Childhood B-Cell
  • +2 more
  • Tafasitamab
  • (no location specified)
Nov 25, 2022

Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Recurrent Leukemia, Refractory Leukemia Trial in Houston (Decitabine, Tegavivint)

Recruiting
  • Recurrent Leukemia
  • Refractory Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • SY-1425 (tamibarotene)
  • +2 more
  • Hartford, Connecticut
  • +25 more
May 4, 2022